1. PKMYT1, exacerbating the progression of clear cell renal cell carcinoma, is implied as a biomarker for the diagnosis and prognosis
    Juan Chen et al, 2021, Aging CrossRef
  2. Structural and energetic insights into the selective inhibition of PKMYT1 against WEE1
    Xuesen Qi et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef

  3. PKMYT1 Promotes Gastric Cancer Cell Proliferation and Apoptosis Resistance


    Qi-Yong Zhang et al, 2020, OncoTargets and Therapy CrossRef
  4. miRDRN—miRNA disease regulatory network: a tool for exploring disease and tissue-specific microRNA regulatory networks
    Hsueh-Chuan Liu et al, 2019, PeerJ CrossRef
  5. DNA Damage Response Inhibitors in Cholangiocarcinoma: Current Progress and Perspectives
    Öykü Gönül Geyik et al, 2022, Cells CrossRef
  6. PD0166285 sensitizes esophageal squamous cell carcinoma to radiotherapy by dual inhibition of WEE1 and PKMYT1
    Qingyi Zhang et al, 2022, Frontiers in Oncology CrossRef
  7. Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma
    Ganghua Zhang et al, 2023, Frontiers in Immunology CrossRef